Global Experts Meeting on Diabetes and Endocrinology

The endocrinology drugs market in the Americas is expected to reach USD 41 billion by 2020, growing at a CAGR of over 6%.The endocrinology drugs market in EMEA will exceed USD 16 billion by 2020, growing at a CAGR of over 6%. The endocrinology drugs market in APAC is expected to exceed USD 14 billion by 2020, growing at a CAGR of over 7%. Key suppliers are Novo Nordisk, Sanofi, Merck, Eli Lilly, AstraZeneca, and AbbVie.

Topics Included for this Diabetes Conference:

Track 1: Endocrinology Research and Development

Track 2: Endocrine Cancer

Track 3: Endocrine Tumor

Track 4: Diabetes and its Treatment

Track 5: Diseases and Disorders

Track 6: Obesity and Metabolism

Track 7: Pregnancy, Reproduction and Infertility

Track 8: Neuropathy

Track 9: Vascular Complications

Track 10: Nutrition Research

Track 11: Challenges and Improvements

Track 12: Management and Prevention

Track 13: Alternative Therapies and Complications

Track 14: Research and Advancements